Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Mabs|September 6, 2016
Methylated α-tubulin antibodies recognize a new microtubule modification on mitotic microtubulesIn Young Park, Pratim Chowdhury, Durga Nand Tripathi, et al.
Gynecologic Oncology|June 10, 2011
Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27Hiroaki Itamochi, Tomokazu Yoshida, Cheryl Lyn Walker, et al.
Toxicologic Pathology|March 17, 2007
Spontaneous renal tubular hyperplastic and neoplastic lesions in three Sprague-Dawley rats from a 90-day toxicity studyWilliam C Hall, Bruce Elder, Cheryl Lyn Walker, et al.
Oncotarget|February 19, 2019
SETD2 loss sensitizes cells to PI3Kβ and AKT inhibitionEsteban A Terzo, Aaron R Lim, Anna Chytil, et al.
Molecular Cancer Research : MCR|March 4, 2003
Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cellsLeslie C Hodges, Jennifer D Cook, Edward K Lobenhofer, et al.
Oncotarget|November 8, 2019
Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibitionEsteban A Terzo, Aaron R Lim, Anna Chytil, et al.
The Journal of Cell Biology|April 26, 2006
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioningSheng-Li Cai, Andrew R Tee, John D Short, et al.
Epigenetics|January 23, 2015
Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostateRebecca Lee Yean Wong, Quan Wang, Lindsey S Treviño, et al.
Molecular Carcinogenesis|February 11, 2010
AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stabilityJohn D Short, Ruhee Dere, Kevin D Houston, et al.
Cancer Research|August 15, 2008
AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27John D Short, Kevin D Houston, Ruhee Dere, et al.
Pageof 6